Literature DB >> 29414815

LncRNA GAS5 Represses Osteosarcoma Cells Growth and Metastasis via Sponging MiR-203a.

Yang Wang, Daliang Kong.   

Abstract

BACKGROUND/AIMS: LncRNA GAS5, a growth suppressor, has been reported to exert anti-tumor actions in various cancers, whereas the exact mechanism underling the anti-tumor action is still unclear. This study was aimed to investigate the effect of lncRNA GAS5 on osteosarcoma and tried to decode the underling mechanisms.
METHODS: Expressions of lncRNA GAS5 in MG-63 cells were silenced by shRNA transfection, while were overexpressed by vector transfection. Cell viability, migration, invasion and apoptosis were respectively assessed by MTT, Transwell assay and flow cytometry. Regulations between lncRNA GAS5 and miR-203a, as well as between miR-203a and TIMP2 were detected by qPCR, western blot and dual luciferase activity assay.
RESULTS: LncRNA GAS5 was down-regulated in MG-63 and OS-732 cells compared to hFOB1.19 cells. Silence of lncRNA GAS5 significantly promoted MG-63 cells viability, migration and invasion, and up-regulated Cyclin D1, Cyclin B1, CDK1 and CDK4 expressions. miR-203a was negatively regulated by lncRNA GAS5. The promoting activities of lncRNA GAS5 silence on MG-63 cells growth and metastasis were reversed by miR-203a suppression. TIMP2 was a target of miR-203a and the anti-growth and anti-metastasis actions of miR-203a suppression were reversed by TIMP2 silence. Further, lncRNA GAS5 silence, miR-203a overexpression, and TIMP2 silence could activate PI3K/AKT/GSK3β signaling while block NF-κB signaling.
CONCLUSION: LncRNA GAS5 might be a tumor suppressor in osteosarcoma via sponging miR-203a, sequestering miR-203a away from TIMP2.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  LncRNA GAS5; MiR-203a; NF-κB signaling; Osteosarcoma; PI3K/AKT/GSK3β signaling; TIMP2

Mesh:

Substances:

Year:  2018        PMID: 29414815     DOI: 10.1159/000487178

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  26 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

Review 2.  Long non-coding RNAs and nuclear factor-κB crosstalk in cancer and other human diseases.

Authors:  Subash C Gupta; Nikee Awasthee; Vipin Rai; Srinivas Chava; Venugopal Gunda; Kishore B Challagundla
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-10-19       Impact factor: 10.680

3.  Osteosarcoma Cell-Derived Exosomal ELFN1-AS1 Mediates Macrophage M2 Polarization via Sponging miR-138-5p and miR-1291 to Promote the Tumorgenesis of Osteosarcoma.

Authors:  Bangmin Wang; Xin Wang; Po Li; Xiaoying Niu; Xiaoxiao Liang; Guancong Liu; Zhiyong Liu; Hong Ge
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

4.  LncRNA CBR3-AS1 promotes osteosarcoma progression through the network of miR-140-5p/DDX54-NUCKS1-mTOR signaling pathway.

Authors:  Weitao Yao; Jingyu Hou; Guoqing Liu; Fangxing Wu; Qiang Yan; Liangyu Guo; Chuchu Wang
Journal:  Mol Ther Oncolytics       Date:  2022-03-08       Impact factor: 6.311

5.  The interplay between HIF-1α and long noncoding GAS5 regulates the JAK1/STAT3 signalling pathway in hypoxia-induced injury in myocardial cells.

Authors:  Yanwei Li; Bing Song; Jinlei Liu; Yuqiang Li; Jiebing Wang; Na Liu; Wei Cui
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

6.  Tanshinone IIA promotes the apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis by up-regulating lncRNA GAS5.

Authors:  Guoqing Li; Ying Liu; Fanru Meng; Zhongbin Xia; Xia Wu; Yuxuan Fang; Chunwang Zhang; Dan Liu
Journal:  Biosci Rep       Date:  2018-10-05       Impact factor: 3.840

7.  Increased expression of lncRNA FTH1P3 predicts a poor prognosis and promotes aggressive phenotypes of laryngeal squamous cell carcinoma.

Authors:  Haozhan Yuan; Hong Jiang; Yanting Wang; Yameng Dong
Journal:  Biosci Rep       Date:  2019-06-18       Impact factor: 3.840

8.  LncRNA-SRA1 Suppresses Osteosarcoma Cell Proliferation While Promoting Cell Apoptosis.

Authors:  Wen Guo; Haitao Jiang; Haijun Li; Fang Li; Qing Yu; Yu Liu; Weiwei Jiang; Ming Zhang
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

Review 9.  Targeting PI3K in cancer: mechanisms and advances in clinical trials.

Authors:  Jing Yang; Ji Nie; Xuelei Ma; Yuquan Wei; Yong Peng; Xiawei Wei
Journal:  Mol Cancer       Date:  2019-02-19       Impact factor: 27.401

10.  Identification of Novel Target for Osteosarcoma by Network Analysis.

Authors:  Li-Qiang Zhi; Yi-Xin Yang; Shu-Xin Yao; Zhong Qing; Jian-Bing Ma
Journal:  Med Sci Monit       Date:  2018-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.